The ESMO congress always disseminates the latest results of cancer research, a vibrant gathering and sharing of the latest data, communicating the next promising steps in oncological scientific ...

Dr Paul Campbell, head of software and AI at the MHRA, said in a recent webinar that AIaMD has the potential to "fix some of ...

Vyloy (zolbetuximab) has been given the go-ahead for use in combination with chemotherapy for the first-line treatment of ...

As usual, a second trial will be needed before UCB and Biogen can file dapirolizumab pegol with regulators. It will be called ...

The Within3 Insights Management Platform gathers, analyses, and reports key insights that drive strategy-impacting decisions ...

The TAGS technology – or Temperature-Activated Generation of Signal to give it its full name – allows up to 15 diagnostic ...

Kayfanda (odevixibat) is labelled in the EU to treat cholestatic pruritus – itching caused by impaired bile formation or flow ...

The FDA has kicked off a priority review of Genfit and Ipsen’s elafibranor as a treatment for rare cholestatic liver disease primary biliary cholangitis (PBC), setting a date of 10th June to ...